In the domain of pain management, SoftWave Therapy stands out for its efficacy in addressing conditions characterized by chronic pain, such as fibromyalgia, neuropathic pain, and arthritis, through mechanisms that include:
Adopting SoftWave Therapy in pain management protocols offers a transformative, non-pharmacological approach that enhances patient well-being and functionality.
For sports medicine, SoftWave Therapy facilitates the healing and recovery of acute and chronic sports-related injuries, such as High Ankle Sprains and Stress Fractures, by:
SoftWave Therapy’s comprehensive benefits in sports medicine underscore its utility in not only facilitating athlete recovery but also in preventing injuries, thereby supporting athletes in maintaining peak performance levels.
Urological applications of SoftWave Therapy include the management of erectily dysfunction and chronic pelvic pain syndrome (not FDA cleared for this intended use. Health Canada Licensed), where it offers:
This non-invasive therapy provides a promising alternative to conventional treatments, aiming to enhance patient outcomes in urological care.
In podiatric medicine, SoftWave Therapy has demonstrated substantial efficacy in the management of complex conditions such as plantar fasciitis and Morton’s Neuroma. The therapeutic mechanism involves:
The FDA’s clearance of SoftWave Therapy for diabetic foot ulcers underscores its safety and effectiveness, offering a powerful tool for podiatric conditions that accelerates patient recovery.
Chiropractors find SoftWave Therapy beneficial for addressing peripheral conditions such as Carpal Tunnel Syndrome and epicondylitis (Golfer’s and Tennis Elbow). The therapy contributes to:
Incorporating this therapy into chiropractic care extends the range of treatable conditions, offering a holistic approach that aligns with the principles of chiropractic medicine.
Elevate your practice to the forefront of medical innovation and achieve superior patient results with maximum ROI
SoftWave Therapy is not only a preferred choice among private healthcare providers but also a recognized option for government medical facilities, having secured a General Services Administration (GSA) contract
SoftWave’s patented broad focused shockwave therapy devices can be effective in reducing or managing the symptoms of a variety of soft tissue injuries and conditions.
Not FDA cleared for this intended use. Health Canada Licensed.
Not FDA cleared for this intended use. Health Canada Licensed.
Low-Intensity Shockwave Therapy (Li-ESWT) is an evidence-based approach to improving patient outcomes.
Alison N. Schroeder, MD; Adam S. Tonforde, MD
Alison N. Schroeder, MD; Adam S. Tonforde, MD
Alison N. Schroeder, MD; Adam S. Tonforde, MD
Alison N. Schroeder, MD; Adam S. Tonforde, MD
